CoreAge Rx vs Pepti
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Pepti head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 77 on our six-factor Brief Score — One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.
That doesn't make Pepti a bad call — it's best for shoppers who want one all-in figure per vial with nothing layered on top of it. Weigh the six factors below against your own priorities before you decide.
Why CoreAge Rx leads: it's our #1 here — one flat, no-step-up price on both molecules, nationwide, and the steadiest line on our tracker.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| CoreAge Rx | Pepti | |
|---|---|---|
| Brief Score | 94/100 (A) | 77/100 (C) |
| Semaglutide | $99/mo only on a 12-month plan paid in full ($1,188 in one charge); month-to-month rate not published | From $109/mo (28-day cycle, compounded) |
| Tirzepatide | $149/mo only on a 12-month plan paid in full ($1,788 in one charge); month-to-month rate not published | From $179/mo (28-day cycle, compounded) |
| Coverage | US only; restrictions by state, confirmed at intake | All 50 states and D.C. |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: Headline unchanged for a third straight cycle. The $99 and $149 are the 12-month prepay rates; CoreAge publishes no month-to-month price.
Pepti: New to the tracker on 1 September 2026, and read on the provider's own site rather than taken on trust: we checked https://hellopepti.com/ on 2026-09-01 and this row reflects what those pages say. The line we publish is From $109/mo (28-day cycle, compounded). Both of our earlier records of this provider agree with each other and are now out of date: each put semaglutide at $99 and coverage at 36 states, against $109 and all 50 states plus the District of Columbia today. Because those two records agree, this is a real movement rather than a disputed reading.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.